| |
| |
|
| Insider
Information: |
Kirk Randal J |
| Relationship: |
10% Owner |
| City: |
Radford |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
3,684,697 |
|
|
Indirect Shares
|
67,796,291 |
|
|
| Direct
Value |
$162,251,771 |
|
|
|
Indirect Value
|
$375,195,594 |
|
|
| Total
Shares |
71,480,988 |
|
|
| Total
Value |
$537,447,365 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
14
|
0
|
|
Stock
price went up :
|
6
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 46.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-08-21 |
4 |
B |
$2.46 |
$30,750 |
I/I |
12,500 |
186,800 |
1.5 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2007-02-26 |
4 |
OE |
$19.45 |
$3,585,802 |
I/I |
184,360 |
193,343 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-08-22 |
4 |
B |
$2.46 |
$43,296 |
I/I |
17,600 |
204,400 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-08-23 |
4 |
B |
$2.49 |
$16,683 |
I/I |
6,700 |
211,100 |
1.5 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2016-12-13 |
4 |
B |
$28.90 |
$1,000,113 |
I/I |
34,606 |
213,805 |
2.64 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-06-13 |
4 |
B |
$5.53 |
$252,859 |
I/I |
45,725 |
218,164 |
2.25 |
- |
|
| PGEN |
Precigen Inc |
Executive Chairman |
• • • |
2020-08-11 |
4 |
B |
$4.50 |
$3,638,331 |
I/I |
808,518 |
218,459 |
2.64 |
% |
|
| PGEN |
Precigen Inc |
Executive Chairman |
• • • |
2020-08-12 |
4 |
B |
$4.26 |
$1,707,689 |
I/I |
400,866 |
220,123 |
2.64 |
% |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2014-03-27 |
4 |
B |
$25.72 |
$6,249,986 |
I/I |
243,001 |
243,001 |
2.64 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-06-16 |
4 |
B |
$5.73 |
$147,834 |
I/I |
25,800 |
243,964 |
2.25 |
- |
|
| PRPO |
Precipio Inc |
10% Owner |
– – • |
2017-08-28 |
4 |
A |
$0.00 |
$0 |
I/I |
813,482 |
271,824 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2012-06-01 |
4 |
B |
$7.39 |
$732,201 |
I/I |
99,080 |
283,840 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-06-17 |
4 |
B |
$5.98 |
$251,160 |
I/I |
42,000 |
285,964 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-08-24 |
4 |
B |
$2.50 |
$233,250 |
I/I |
93,300 |
304,400 |
1.5 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • • |
2021-11-19 |
4 |
B |
$3.75 |
$1,153,729 |
I/I |
307,661 |
307,661 |
2.25 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-06-18 |
4 |
B |
$5.76 |
$212,124 |
I/I |
36,827 |
322,791 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2012-06-04 |
4 |
B |
$7.37 |
$660,691 |
I/I |
89,646 |
328,663 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2012-06-05 |
4 |
B |
$7.48 |
$40,863 |
I/I |
5,463 |
331,394 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-08-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
340,000 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2007-05-15 |
4 |
A |
$10.37 |
$155,550 |
D/D |
15,000 |
355,000 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-05-18 |
4 |
B |
$20.00 |
$2,000,000 |
I/I |
100,000 |
366,246 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
370,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-06-19 |
4 |
B |
$6.02 |
$360,598 |
I/I |
59,900 |
382,691 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-08-25 |
4 |
B |
$2.50 |
$277,250 |
I/I |
110,900 |
415,300 |
1.5 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-06-13 |
4 |
A |
$16.27 |
$5,999,996 |
I/I |
368,720 |
429,912 |
|
- |
|
271 Records found
|
|
Page 3 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
